Diastika Biotekindo corrects IPO fund-use report, cites IDR 25.04 billion remaining proceeds

PUBT · 2d ago
Diastika Biotekindo corrects IPO fund-use report, cites IDR 25.04 billion remaining proceeds
  • PT Diastika Biotekindo issued a correction to its July 15, 2026 report on IPO proceeds usage.
  • IPO proceeds totaled IDR 110.39 billion; offering costs IDR 3.59 billion; net proceeds IDR 106.80 billion.
  • Realized use of funds reached IDR 81.76 billion; remaining funds IDR 25.04 billion.
  • Remaining funds placement included IDR 25.00 billion at Bank UOB at 4.1%; IDR 42,040,096 at Bank BCA at 0.01%.
  • Largest realized allocation was inventory purchases at IDR 75.81 billion, representing 75.26% of net proceeds.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PT Diastika Biotekindo Tbk published the original content used to generate this news brief via Indonesia Stock Exchange (IDX) (Ref. ID: 32164319) on October 07, 2026, and is solely responsible for the information contained therein.